Publication: Active R-RAS2/TC21 prevents cell cycle arrest and morphological alterations in mouse embryonic fibroblasts lacking RAS proteins.
| dc.contributor.author | Fernández-Pisonero, Isabel | |
| dc.contributor.author | Lorenzo-Martín, L Francisco | |
| dc.contributor.author | Drosten, Mattias | |
| dc.contributor.author | Santos, Eugenio | |
| dc.contributor.author | Barbacid, Mariano | |
| dc.contributor.author | Alarcón, Balbino | |
| dc.contributor.author | Bustelo, Xosé R | |
| dc.contributor.funder | La Caixa | |
| dc.contributor.funder | Asociaciacion Española Contra el Cancer | |
| dc.contributor.funder | MCIN/AEI | |
| dc.date.accessioned | 2025-06-18T08:46:08Z | |
| dc.date.available | 2025-06-18T08:46:08Z | |
| dc.date.issued | 2025-07 | |
| dc.description.abstract | R-RAS2/TC21, a member of the R-RAS subfamily of GTP-binding proteins, shares structural and signaling properties with the RAS subfamily proteins H-, K-, and N-RAS. However, little information is available regarding its role in normal cells and the level of functional redundancy with R-RAS and classical RAS proteins. In this work, we used loss and gain-of-function approaches to assess these issues in mouse embryonic fibroblasts (MEFs). Using primary MEFs from Rras2, Rras or Rras; Rras2 embryos, we show here that endogenous R-RAS2/TC21 is required for activation of the phosphatidylinositol 3 kinase (PI3K)-AKT axis, the proliferation, and the adhesion properties of these cells. Endogenous R-RAS does not influence any of these cell parameters. We also show that the depletion of R-RAS2/TC21 worsens the proliferative and morphological defects elicited by the combined loss of H-, K- and N-RAS proteins in MEFs. Conversely, the ectopic expression of an active version of R-RAS2/TC21, but not of R-RAS, overcomes such defects. This rescue activity involves the inhibition of the tumor suppressor TP53 and is PI3K-, mTORC-, and MEK/ERK-dependent. These results indicate that R-RAS2/TC21, R-RAS, and RAS subfamily GTPases play different roles in MEFs. They also show that R-RAS2 provides subsidiary signals that are essential for the short-term proliferation and long-term viability of MEFs lacking RAS signaling. | |
| dc.description.peerreviewed | Sí | |
| dc.description.tableofcontents | The XRB's project leading to these results has received funding from the Spanish Association against Cancer (GC16173472GARC), the Castilla-Leon government (CSI018P23), grants funded by MCIN/AEI/10.13039/501100011033/ plus the European Research Development Fund << A way of making Europe >> of the European Union (PID2021-122666OB-I00, PDC2022-133027-I00, PLEC2022-009217), << la Caixa >> Banking Foundation (HR20-00164), the << Programa Excelencia >> of the Fundacion Cientifica AECC 2022 (EPAEC222641CICS), and the << Escalera de Excelencia >> of the Education Ministry of the Castilla y Leon autonomous government plus the European Research Development Fund (CLU-2023-2-01). | |
| dc.format.number | 24 | |
| dc.format.page | 1905-1921 | |
| dc.format.volume | 44 | |
| dc.identifier.citation | Oncogene . 2025 Jul;44(24):1905-1921. | |
| dc.identifier.journal | Oncogene | |
| dc.identifier.pubmedID | 40164870 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12105/26763 | |
| dc.language.iso | eng | |
| dc.publisher | Nature Publishing Group | |
| dc.relation.projectID | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2021-122666OB-I00/ES/DISECCION DEL PAPEL PATOBIOLOGICO Y TERAPEUTICO DE UN NUEVO DRIVER ONCOGENICO EN LINFOMAS DE CELULAS T/ | |
| dc.relation.projectID | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PDC2022-133027-I00/ES/OPTIMIZACION ORIENTADA AL MERCADO THE INHIBIDORES DE LA ACTIVIDAD CATALITICA DE LA ONCOPROTEINA VAV1/ | |
| dc.relation.projectID | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PLEC2022-009217/ES/ENCAPSULACIÓN DE CÉLULAS CART EN SISTEMAS POROSOS NANOESTRUCTURADOS BIOACTIVOS PARA SU LIBERACIÓN DIRIGIDA EN TUMORES SOLIDOS/ | |
| dc.relation.projectID | E | |
| dc.relation.publisherversion | http://doi: 10.1038/s41388-025-03367-3. | |
| dc.repisalud.institucion | CNIO | |
| dc.repisalud.orgCNIO | CNIO::Grupos de investigación::Grupo de Oncología Experimental | |
| dc.rights.accessRights | open access | |
| dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | HUMAN R-RAS | |
| dc.subject | TC21 | |
| dc.subject | ACTIVATION | |
| dc.subject | TRANSFORMATION | |
| dc.subject | MIGRATION | |
| dc.subject | PROLIFERATION | |
| dc.subject | TC21/R-RAS2 | |
| dc.subject | EXPRESSION | |
| dc.subject | KINASE | |
| dc.title | Active R-RAS2/TC21 prevents cell cycle arrest and morphological alterations in mouse embryonic fibroblasts lacking RAS proteins. | |
| dc.type | research article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 728b1f96-276b-4ab5-8640-8964fb72939f | |
| relation.isAuthorOfPublication.latestForDiscovery | 728b1f96-276b-4ab5-8640-8964fb72939f |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ActiveRRAS2TC21prevents_2025.pdf
- Size:
- 12.74 MB
- Format:
- Adobe Portable Document Format


